Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Ulinastatin market size was valued at USD 265.48 million in 2022 and is expected to expand at a CAGR of 16.59% during the forecast period, reaching USD 666.97 million by 2028.
Ulinastatin is a multivalent Kunitz-type serine protease inhibitor derived from human urine, with potential protective, anti-fibrinolytic and anticoagulant activities. Upon administration, ulinastatin (or urinary trypsinogen inhibitor) inhibits the activities of a variety of enzymes, including trypsin, chymotrypsin, thrombin, kallikrein, plasmin, elastase, cathepsin, lipase, hyaluronidase, factors IXa, Xa, XIa, and XlIa, and polymorphonuclear leukocyte elastase. In addition, ulinastatin inhibits the excessive release of proinflammatory mediators, such as tumor necrosis factor-alpha, interleukin-6 and -8, and chemokines. Altogether, this agent may improve the microcirculation, perfusion and function of tissues and may protect organ injury.
COVID-19's impact on the Ulinastatin industry
In the specific environment based on the outbreak of COVID-19, the global economy has been significantly affected, resulting in challenges and opportunities for the development status of various industries. The report is based on the impact of COVID-19 and conducts research on the Ulinastatin industry from different perspectives such as macroeconomics, industrial chains, and regions.
Market Driver Analysis
Ulinastatin is an inhibitor of trypsin. It may be isolated from human urine or can be developed artificially and synthetically. Having its use in treatment of diseases like acute or chronic pancreatitis, burns, sepsis, toxic epidermal necrolysis; it works by inactivating serine proteases. It also reduces inflammations as a result of sepsis, trauma or surgery. In severe sepsis the symptoms are cardiovascular organ dysfunction, acute respiratory distress syndrome etc. Causes are trauma, burn or pneumonia. In such condition Ulinastatin can be an effective medication being given intravenously.
As Ulinastatin is widely used in clinical treatment of various diseases, its downstream demand has increased, which has promoted the development of the Ulinastatin industry.
The production of crude ulinastatin by traditional technology requires the collection of male urine. The process is cumbersome, difficult to collect, and easy to pollute the environment through multiple acid-base adjustments of the urine, and step-by-step processing to extract protein materials. The process is cumbersome and difficult to collect. With the advancing process of industrialization, rising labor costs and increasing environmental sanitation requirements, the traditional production methods of crude Ulinastatin have received many restrictions.
Market Restraints Analysis
At present, the crude products of Ulinastatin need to be extracted or adsorbed from human urine regardless of the traditional process or resin adsorption process, which has inherent weaknesses such as large resource dependence, long transportation distance and low production efficiency.
In addition, the pharmaceutical industry is among the industries with higher environmental regulation requirements. With the increasing attention to environmental protection issues, countries have formulated stricter environmental standards and norms, and carried out relevant environmental supervision work. If governments around the world issue new laws and regulations in the future to further enhance environmental regulatory requirements, it will make Ulinastatin manufacturing companies to pay higher environmental fees, which may have a certain impact on its profit level.
The resin adsorption process of Ulinastatin does not need to collect urine, which can be used to collect raw materials in high human flow areas of large cities and reduce environmental pollution compared to traditional production methods.
Region Overview:
China had the highest growth rate of all regions.
Company Overview:
Techpool is one of the major players operating in the Ulinastatin market, holding a share of 88.70% in 2021.
Techpool Bio-Pharma Co. Ltd. manufactures drugs. The Company researches, develops, produces, and sells urinary protein biopharmaceuticals. Guangdong Techpool Bio-Pharma mainly provides its products for critical care fields.
Han Lim Pharmaceutical's business scope includes the manufacture of bulk organic and inorganic pharmaceutical chemicals.
Segmentation Overview:
Among different product types, Powder segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Acute Pancreatitis segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Ulinastatin industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Ulinastatin. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Ulinastatin Market Report Include:
Market Size Estimates: Ulinastatin market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Ulinastatin market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Ulinastatin market
Segment Market Analysis: Ulinastatin market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Ulinastatin market situations and prospects in major and top regions and countries
Ulinastatin Market
Ulinastatin Industry Chain: Ulinastatin market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Ulinastatin Industry News, Policies by regions
Ulinastatin Industry Porters Five Forces Analysis
Key players in the global Ulinastatin market are covered in Chapter 2:
Bharat Serums & Vaccines Ltd. (Altius)
Han Lim Pharmaceutical
Mochida Pharmaceuticals
Lupin
Techpool
In Chapter 6 and Chapter 9, on the basis of types, the Ulinastatin market from 2018 to 2028 is primarily split into:
Powder
Injection
In Chapter 7 and Chapter 10, on the basis of applications, the Ulinastatin market from 2018 to 2028 covers:
Sepsis
Acute Pancreatitis
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Ulinastatin market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Ulinastatin industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Ulinastatin market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Ulinastatin industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Ulinastatin market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Ulinastatin market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Ulinastatin market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Ulinastatin is a multivalent Kunitz-type serine protease inhibitor derived from human urine, with potential protective, anti-fibrinolytic and anticoagulant activities. Upon administration, ulinastatin (or urinary trypsinogen inhibitor) inhibits the activities of a variety of enzymes, including trypsin, chymotrypsin, thrombin, kallikrein, plasmin, elastase, cathepsin, lipase, hyaluronidase, factors IXa, Xa, XIa, and XlIa, and polymorphonuclear leukocyte elastase. In addition, ulinastatin inhibits the excessive release of proinflammatory mediators, such as tumor necrosis factor-alpha, interleukin-6 and -8, and chemokines. Altogether, this agent may improve the microcirculation, perfusion and function of tissues and may protect organ injury.
COVID-19's impact on the Ulinastatin industry
In the specific environment based on the outbreak of COVID-19, the global economy has been significantly affected, resulting in challenges and opportunities for the development status of various industries. The report is based on the impact of COVID-19 and conducts research on the Ulinastatin industry from different perspectives such as macroeconomics, industrial chains, and regions.
Market Driver Analysis
Ulinastatin is an inhibitor of trypsin. It may be isolated from human urine or can be developed artificially and synthetically. Having its use in treatment of diseases like acute or chronic pancreatitis, burns, sepsis, toxic epidermal necrolysis; it works by inactivating serine proteases. It also reduces inflammations as a result of sepsis, trauma or surgery. In severe sepsis the symptoms are cardiovascular organ dysfunction, acute respiratory distress syndrome etc. Causes are trauma, burn or pneumonia. In such condition Ulinastatin can be an effective medication being given intravenously.
As Ulinastatin is widely used in clinical treatment of various diseases, its downstream demand has increased, which has promoted the development of the Ulinastatin industry.
The production of crude ulinastatin by traditional technology requires the collection of male urine. The process is cumbersome, difficult to collect, and easy to pollute the environment through multiple acid-base adjustments of the urine, and step-by-step processing to extract protein materials. The process is cumbersome and difficult to collect. With the advancing process of industrialization, rising labor costs and increasing environmental sanitation requirements, the traditional production methods of crude Ulinastatin have received many restrictions.
Market Restraints Analysis
At present, the crude products of Ulinastatin need to be extracted or adsorbed from human urine regardless of the traditional process or resin adsorption process, which has inherent weaknesses such as large resource dependence, long transportation distance and low production efficiency.
In addition, the pharmaceutical industry is among the industries with higher environmental regulation requirements. With the increasing attention to environmental protection issues, countries have formulated stricter environmental standards and norms, and carried out relevant environmental supervision work. If governments around the world issue new laws and regulations in the future to further enhance environmental regulatory requirements, it will make Ulinastatin manufacturing companies to pay higher environmental fees, which may have a certain impact on its profit level.
The resin adsorption process of Ulinastatin does not need to collect urine, which can be used to collect raw materials in high human flow areas of large cities and reduce environmental pollution compared to traditional production methods.
Region Overview:
China had the highest growth rate of all regions.
Company Overview:
Techpool is one of the major players operating in the Ulinastatin market, holding a share of 88.70% in 2021.
Techpool Bio-Pharma Co. Ltd. manufactures drugs. The Company researches, develops, produces, and sells urinary protein biopharmaceuticals. Guangdong Techpool Bio-Pharma mainly provides its products for critical care fields.
Han Lim Pharmaceutical's business scope includes the manufacture of bulk organic and inorganic pharmaceutical chemicals.
Segmentation Overview:
Among different product types, Powder segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Acute Pancreatitis segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Ulinastatin industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Ulinastatin. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Ulinastatin Market Report Include:
Market Size Estimates: Ulinastatin market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Ulinastatin market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Ulinastatin market
Segment Market Analysis: Ulinastatin market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Ulinastatin market situations and prospects in major and top regions and countries
Ulinastatin Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Ulinastatin Industry Chain: Ulinastatin market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Ulinastatin Industry News, Policies by regions
Ulinastatin Industry Porters Five Forces Analysis
Key players in the global Ulinastatin market are covered in Chapter 2:
Bharat Serums & Vaccines Ltd. (Altius)
Han Lim Pharmaceutical
Mochida Pharmaceuticals
Lupin
Techpool
In Chapter 6 and Chapter 9, on the basis of types, the Ulinastatin market from 2018 to 2028 is primarily split into:
Powder
Injection
In Chapter 7 and Chapter 10, on the basis of applications, the Ulinastatin market from 2018 to 2028 covers:
Sepsis
Acute Pancreatitis
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Ulinastatin market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Ulinastatin industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Ulinastatin market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Ulinastatin industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Ulinastatin market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Ulinastatin market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Ulinastatin market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
